TherapeuticsMD (TXMD) Asset Writedowns and Impairment (2012 - 2025)
TherapeuticsMD's (TXMD) quarterly Asset Writedowns and Impairment came in at $1.3 million in Q1 2025, up 17914.29% on a QoQ basis from $7000.0 in Q4 2024.
TherapeuticsMD (TXMD) Asset Writedowns and Impairment (2012 - 2025) Analysis & Trends
TherapeuticsMD (TXMD) has 14 years of Asset Writedowns and Impairment data on file, last reported at $1.3 million in Q1 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.3 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.3 million (changed N/A YoY) and the FY2024 annual result came in at $1.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment rose to $1.3 million in Q1 2025, from $7000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.3 million in Q1 2025 to a low of -$7000.0 in Q4 2021.
- A 5-year average of $266888.9 and a median of $215000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 462.08% in 2021, down 101.4% in 2021.
- Tracing TXMD's Asset Writedowns and Impairment over 5 years: stood at -$7000.0 in 2021, then surged by 3928.57% to $268000.0 in 2022, then tumbled by 77.99% to $59000.0 in 2023, then plunged by 88.14% to $7000.0 in 2024, then jumped by 17914.29% to $1.3 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $1.3 million (Q1 2025), $7000.0 (Q4 2024), and $59000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Jun 30, 2022 | 268,000.00 |
| Jun 30, 2022 | 268,000.00 |
| Mar 31, 2022 | 274,000.00 |
| Mar 31, 2022 | 274,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | 95,000.00 |
| Sep 30, 2021 | 95,000.00 |
| Jun 30, 2021 | 215,000.00 |
| Jun 30, 2021 | 215,000.00 |
| Mar 31, 2021 | 230,000.00 |
| Mar 31, 2021 | 230,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |